Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET
Cryoport (Nasdaq: CYRX), a leading global supply chain solutions provider for the life sciences industry, has announced an investor call scheduled for March 31, 2025, at 8:30 a.m. ET. The call will focus on discussing the company's recent strategic partnership with DHL Group and DHL's acquisition of CRYOPDP.
The conference call will feature management team presentations followed by a Q&A session addressing investor inquiries about these developments. A slide deck will accompany the presentation.
The recorded call will be available approximately three hours after completion in the Investor Relations section at www.cryoportinc.com. A dial-in replay will be accessible until April 7, 2025, via:
- United States: 1-844-512-2921
- International: 1-412-317-6671
- Replay entry code: 1197941#
Cryoport (Nasdaq: CYRX), un fornitore leader di soluzioni per la catena di approvvigionamento nel settore delle scienze della vita, ha annunciato una chiamata per gli investitori programmata per il 31 marzo 2025, alle 8:30 ET. La chiamata si concentrerà sulla recente partnership strategica con DHL Group e sull'acquisizione di CRYOPDP da parte di DHL.
La conferenza telefonica presenterà le relazioni del team di gestione seguite da una sessione di domande e risposte per affrontare le domande degli investitori su questi sviluppi. Una presentazione in formato slide accompagnerà l'incontro.
La chiamata registrata sarà disponibile circa tre ore dopo il termine nella sezione Relazioni con gli Investitori su www.cryoportinc.com. Una registrazione della chiamata sarà accessibile fino al 7 aprile 2025, tramite:
- Stati Uniti: 1-844-512-2921
- Internazionale: 1-412-317-6671
- Codice di accesso alla registrazione: 1197941#
Cryoport (Nasdaq: CYRX), un proveedor líder de soluciones de cadena de suministro para la industria de ciencias de la vida, ha anunciado una llamada para inversores programada para el 31 de marzo de 2025, a las 8:30 a.m. ET. La llamada se centrará en discutir la asociación estratégica reciente con DHL Group y la adquisición de CRYOPDP por parte de DHL.
La conferencia telefónica contará con presentaciones del equipo directivo seguidas de una sesión de preguntas y respuestas para abordar las consultas de los inversores sobre estos desarrollos. Una presentación en formato de diapositivas acompañará la reunión.
La llamada grabada estará disponible aproximadamente tres horas después de su finalización en la sección de Relaciones con Inversores en www.cryoportinc.com. Una repetición de la llamada será accesible hasta el 7 de abril de 2025, a través de:
- Estados Unidos: 1-844-512-2921
- Internacional: 1-412-317-6671
- Código de entrada para la repetición: 1197941#
크라이오포트 (Nasdaq: CYRX)는 생명 과학 산업을 위한 글로벌 공급망 솔루션 제공업체로, 2025년 3월 31일 오전 8시 30분 ET에 예정된 투자자 전화 회의를 발표했습니다. 이번 회의는 DHL 그룹과의 최근 전략적 파트너십 및 DHL의 CRYOPDP 인수에 대해 논의하는 데 중점을 둘 것입니다.
컨퍼런스 콜에서는 경영진의 발표가 진행된 후, 이러한 발전에 대한 투자자의 질문을 다루는 Q&A 세션이 이어집니다. 발표에는 슬라이드 자료가 함께 제공될 것입니다.
녹음된 통화는 완료 약 3시간 후에 www.cryoportinc.com의 투자자 관계 섹션에서 확인할 수 있습니다. 통화 재생은 2025년 4월 7일까지 다음 번호로 접근할 수 있습니다:
- 미국: 1-844-512-2921
- 국제: 1-412-317-6671
- 재생 입력 코드: 1197941#
Cryoport (Nasdaq: CYRX), un fournisseur mondial de premier plan de solutions de chaîne d'approvisionnement pour l'industrie des sciences de la vie, a annoncé un appel aux investisseurs prévu pour le 31 mars 2025 à 8h30 ET. L'appel se concentrera sur la partenariat stratégique récent avec le groupe DHL et l'acquisition de CRYOPDP par DHL.
La conférence téléphonique comprendra des présentations de l'équipe de direction suivies d'une session de questions-réponses pour répondre aux interrogations des investisseurs sur ces développements. Une présentation sous forme de diaporama accompagnera la réunion.
L'appel enregistré sera disponible environ trois heures après la fin dans la section Relations avec les investisseurs sur www.cryoportinc.com. Un accès à la répétition sera accessible jusqu'au 7 avril 2025, via :
- États-Unis : 1-844-512-2921
- International : 1-412-317-6671
- Code d'accès à la répétition : 1197941#
Cryoport (Nasdaq: CYRX), ein führender Anbieter von Lösungen für die Lieferkette in der Biowissenschaftsindustrie, hat einen Investorencall für den 31. März 2025 um 8:30 Uhr ET angekündigt. Der Call wird sich auf die strategische Partnerschaft mit der DHL Group und die Übernahme von CRYOPDP durch DHL konzentrieren.
Die Telefonkonferenz wird Präsentationen des Management-Teams beinhalten, gefolgt von einer Q&A-Session, in der Fragen der Investoren zu diesen Entwicklungen behandelt werden. Eine Präsentation in Form von Folien wird die Sitzung begleiten.
Der aufgezeichnete Call wird etwa drei Stunden nach Abschluss im Bereich Investor Relations auf www.cryoportinc.com verfügbar sein. Eine Rückrufwiederholung ist bis zum 7. April 2025 über folgende Nummern zugänglich:
- Vereinigte Staaten: 1-844-512-2921
- International: 1-412-317-6671
- Wiederholungszugangscode: 1197941#
- None.
- None.
The conference call will include remarks by the management team followed by a questions and answers session that will address questions members of the investment community have regarding these recent events. A slide deck will accompany the call.
Conference Call Information
Date: | Monday, March 31, 2025 |
Time: | 8:30 a.m. ET, 4:30 PM (UTC+1) |
Dial-in numbers: | 1-800-717-1738 ( |
Confirmation code: | Request the "Cryoport Call" or Conference ID: 1197941 |
Live webcast: | 'Investor Relations' section at www.cryoportinc.com or click here.
Please allow 10 minutes prior to the call to visit this site to download and install any necessary audio software. |
The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company's website at www.cryoportinc.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until April 7, 2025. To access the replay, dial 1-844-512-2921 (
About Cryoport, Inc
Cryoport, Inc. (Nasdaq: CYRX), is a global leader in supply chain solutions for the Life Sciences with an emphasis on cell & gene therapies. Cryoport enables manufacturers, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers to carry out their respective business with products and services that are designed to derisk services and provide certainty. We provide a broad array of supply chain solutions for the life sciences industry. Through our platform of critical products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, we are "Enabling the Future of Medicine™" worldwide, through our innovative systems, compliant procedures, and agile approach to superior supply chain management.
Our corporate headquarters, located in
For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X, formerly known as Twitter at www.x.com/cryoport for live updates.
Forward-Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, those related to Cryoport's expectations about future benefits of the sale of CRYOPDP and the strategic collaboration with DHL, including the potential impact on future revenue and revenue streams. It is important to note that Cryoport's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport's cash flow, market acceptance risks, and technical development risks. Cryoport's business could be affected by other factors discussed in Cryoport's SEC reports, including in the "Risk Factors" section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-to-host-investor-call-to-discuss-recent-strategic-agreement-and-transformative-transaction-today-march-31-2025-at-830-am-et-302415562.html
SOURCE Cryoport, Inc.
FAQ
What is the strategic partnership announced between Cryoport (CYRX) and DHL Group in March 2025?
When is Cryoport's investor call to discuss the DHL partnership and how can investors access it?
What are the replay options for Cryoport's March 2025 strategic partnership announcement call?
How will the DHL acquisition of CRYOPDP impact Cryoport's operations?
